Shandong Weigao Blood Purification Products Co., Ltd. (SHSE: 603014)
Health Care · Health Care Equipment & Supplies · CN
CN¥33.87
+0.03% today · -16.4% 1Y
Shandong Weigao Blood Purification Products Co., Ltd. (SHSE: 603014) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.10B.
Over the last twelve months the share price has lost 16.4%, trading between 29.70 and 49.01.
Tweenvest scores Shandong Weigao Blood Purification Products Co., Ltd. across four factors: quality 69/100, value 77/100, dividend 47/100. Its strongest factor is value.
603014 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.10B
- Revenue (TTM)
- $547.60M
- P/E
- 28.26
- EPS
- 1.20
- Dividend yield
- 1.53%
- Beta (5Y)
- —
- 52-week high
- CN¥49.01
- 52-week low
- CN¥29.70
- Avg volume (3M)
- —
- Shares outstanding
- 417.75M
- Employees
- —
- Next earnings
- —
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.